JNVR (Janover Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by JNVR officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-24 | Parker White | 10%+ Owner | Buy | — | — |
| 2026-08-21 | Daniel Kang | Chief Strategy Officer | Buy | — | — |
| 2026-08-18 | Fei Han | Chief Financial Officer | F | — | — |
| 2026-08-17 | Daniel Kang | Chief Strategy Officer | Buy | — | — |
| 2026-07-20 | Fei Han | Chief Financial Officer | F | — | — |
| 2026-06-22 | Fei Han | Chief Financial Officer | F | — | — |
| 2026-05-18 | Fei Han | Chief Financial Officer | F | — | — |
| 2026-04-21 | Fei Han | Chief Financial Officer | F | — | — |
| 2026-04-06 | Adam R. Townsend | Director | A | — | — |
| 2026-04-03 | BLAKE JANOVER | Director | MIXED | — | — |
| 2026-04-02 | Thomas J. Perfumo | Director | A | — | — |
| 2026-04-02 | Daniel Kang | Chief Strategy Officer | A | — | — |
| 2026-04-02 | Joseph Mario Onorati | CEO & Chairman | A | — | — |
| 2026-04-02 | Zachary Aris Tai | Director | A | — | — |
| 2026-04-02 | Parker White | COO & Chief Investment Officer | A | — | — |
| 2026-04-02 | BLAKE JANOVER | Director | A | — | — |
| 2026-04-02 | Fei Han | Chief Financial Officer | A | — | — |
| 2026-04-02 | William J Caragol | Director | A | — | — |
| 2026-03-18 | Fei Han | Chief Financial Officer | F | — | — |
| 2026-03-03 | SAMUEL DRAYTON HASKELL | Director | A | — | — |
| 2026-02-26 | MARCELO LEMOS | Director | A | — | — |
| 2026-02-19 | Parker White | COO & Chief Investment Officer | A | — | — |
| 2026-02-19 | Thomas J. Perfumo | Director | A | — | — |
| 2026-02-19 | William J Caragol | Director | A | — | — |
| 2026-02-19 | Joseph Mario Onorati | CEO & Chairman | A | — | — |
| 2026-02-19 | Zachary Aris Tai | Director | A | — | — |
| 2026-02-19 | Fei Han | Chief Financial Officer | A | — | — |
| 2026-02-19 | Daniel Kang | Chief Strategy Officer | A | — | — |
| 2026-01-29 | Hadley R. Stern | Director | A | — | — |
| 2026-01-08 | NED L SIEGEL | Director | A | — | — |
| 2026-01-07 | William J Caragol | Director | A | — | — |
| 2025-12-19 | Joseph Mario Onorati | CEO & Chairman | A | — | — |
| 2025-12-19 | Daniel Kang | Chief Strategy Officer | A | — | — |
| 2025-12-19 | Fei Han | Chief Financial Officer | A | — | — |
| 2025-12-19 | Parker White | COO & Chief Investment Officer | A | — | — |
| 2025-12-11 | Parker White | COO, CHIEF INVESTMENT OFFICER | Buy | — | — |
| 2025-12-03 | Joseph Mario Onorati | CEO & Chairman | G | — | — |
| 2025-11-25 | Parker White | COO & Chief Investment Officer | MIXED | — | — |
| 2025-11-25 | Daniel Kang | Chief Strategy Officer | MIXED | — | — |
| 2025-11-25 | Fei Han | Chief Financial Officer | J | — | — |
| 2025-11-25 | Joseph Mario Onorati | CEO & Chairman | J | — | — |
| 2025-10-23 | Thomas J. Perfumo | Director | A | — | — |
| 2025-09-23 | Daniel Kang | Chief Strategy Officer | A | — | — |
| 2025-08-01 | Zachary Aris Tai | Director | A | — | — |
| 2025-05-05 | Parker White | COO, CHIEF INVESTMENT OFFICER | A | — | — |
| 2025-04-11 | BLAKE JANOVER | CHIEF COMMERICAL OFFICER | A | — | — |
| 2025-04-11 | Joseph Mario Onorati | CEO & Chairman | A | — | — |
| 2025-04-11 | BRUCE S ROSENBLOOM | Chief Financial Officer | A | — | — |
| 2025-04-11 | Parker White | COO, CHIEF INVESTMENT OFFICER | A | — | — |
| 2025-04-11 | Marco Santori | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Chief Financial Officer | 826,149 | — |
| — | COO & Chief Investment Officer | 608,785 | — |
| — | CHIEF COMMERICAL OFFICER | 61,236 | — |
| — | Director | 54,500 | — |
| — | Chief Strategy Officer | 31,181 | — |
| — | Chief Financial Officer | 29,313 | — |
| — | Director | 28,170 | — |
| — | Director | 21,357 | — |
| — | Director | 16,500 | — |
| — | Director | 14,500 | — |
| — | Director | 14,000 | — |
| — | Director | 5,092 | — |
| — | CEO & Chairman | 4,500 | — |
| — | Director | 1,250 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the JNVR quote page; the site-wide leaderboard is on the insider transactions hub.